The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Cancer Cell Lines Are Useful Model Systems for Medical Research
Open accessAbstract
Cell lines are in vitro model systems that are widely used in different fields of medical research, especially basic cancer research and drug discovery. Their usefulness is primarily linked to their ability to provide an indefinite source of biological material for experimental purposes. Under the right conditions and with appropriate controls, authenticated cancer cell lines retain most of the genetic properties of the cancer of origin. During the last few years, comparing genomic data of most cancer cell lines has corroborated this statement and those that were observed studying the tumoral tissue equivalents included in the The Cancer Genome Atlas (TCGA) database. We are at the disposal of comprehensive open access cell line datasets describing their molecular and cellular alterations at an unprecedented level of accuracy. This aspect, in association with the possibility of setting up accurate culture conditions that mimic the in vivo microenvironment (e.g., three-dimensional (3D) coculture), has strengthened the importance of cancer cell lines for continuing to sustain medical research fields. However, it is important to consider that the appropriate use of cell lines needs to follow established guidelines for guaranteed data reproducibility and quality, and to prevent the occurrence of detrimental events (i.e., those that are linked to cross-contamination and mycoplasma contamination).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 1×
“In parallel to advancements in the knowledge of genetics and transcriptomics of cancer cell lines, The Cancer Genome Atlas (TCGA) database [51] revealed the great molecular diversity among tumors across and within cancer types.”
BackgroundThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · cited 3×
“[15] are extremely useful when a novel defect at the DNA level or a difference in gene or protein expression is detected in a specific cancer type.”
BackgroundMethodChemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.1.191 · Cited by 1,671
Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell lines
Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A., & Wollheim, C. B. (1992) · Endocrinology · doi:10.1210/en.130.1.167 · Cited by 1,165
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 937
Lanotte, M., Martin-Thouvenin, V, Najman, S., Balerini, P., Valensi, F., & Berger, R. (1991) · Blood · doi:10.1182/blood.v77.5.1080.1080 · Cited by 883
O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., et al. (1997) · PubMed · Cited by 867
STUDIES ON THE PROPAGATION IN VITRO OF POLIOMYELITIS VIRUSES
Scherer, W. F., Syverton, J. T., & Gey, G. O. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.97.5.695 · Cited by 856
A comprehensive transcriptional portrait of human cancer cell lines
Klijn, C., Durinck, S., Stawiski, E. W., Haverty, P. M., Jiang, Z., Liu, H., Degenhardt, J., Mayba, O., Gnad, F., Liu, J., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3080 · Cited by 660
CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)
Pulvertaft, R. J. V. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92345-1 · Cited by 626
The emerging clinical relevance of genomics in cancer medicine
Berger, M. F., & Mardis, E. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0002-6 · Cited by 626
A new human prostate carcinoma cell line, 22Rv1
Sramkoski, R. M., Pretlow, T. G., Giaconia, J. M., Pretlow, T. P., Schwartz, S., Sy, M.-S., Marengo, S. R., Rhim, J. S., Zhang, D., & Jacobberger, J. W. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0115-4 · Cited by 591
HeLa cells 50 years on: the good, the bad and the ugly
Masters, J. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc775 · Cited by 560
The landscape of cancer cell line metabolism
Li, H., Ning, S., Ghandi, M., Kryukov, G. V., Gopal, S., Deik, A., Souza, A., Pierce, K., Keskula, P., Hernandez, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0404-8 · Cited by 525
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 4×
“published [19] and made available online (https://en.”
BackgroundInfluentialShort tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478 · cited 1×
“In this context, it is important to consider that a variety of methods are available for authentication; for human cell lines, short tandem repeat (STR) profiling is the current international reference standard and it is recommended as an easy and economical way to confirm cell line identity by comparison to donor tis…”
BackgroundGuidelines for the use of cell lines in biomedical research
Geraghty, R. J., Capes-Davis, A., Davis, J. M., Downward, J., Freshney, R. I., Knezevic, I., Lovell-Badge, R., Masters, J. R. W., Meredith, J., Stacey, G. N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.166 · Cited by 464
Biobanking in health care: evolution and future directions
Coppola, L., Cianflone, A., Grimaldi, A. M., Incoronato, M., Bevilacqua, P., Messina, F., Baselice, S., Soricelli, A., Mirabelli, P., & Salvatore, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1922-3 · Cited by 394
Self-citationCoecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Human cancer cell lines: fact and fantasy
Masters, J. R. W. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043102 · Cited by 352
Drexler, H. G., & Uphoff, C. C. (2002) · Cytotechnology · doi:10.1023/a:1022913015916 · Cited by 340 · cited 1×
“Unfortunately, the stabilization of a number of cell lines, especially during the 1970s and 1980s, was followed by the generation of two pitfalls that were related to their use: cross-contamination and mycoplasma contamination [61,88].”
BackgroundCross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329 · cited 2×
“In a pioneering study, he was able to prove the authenticity of each newly established cell line by means of DNA fingerprint analysis [60].”
BackgroundHolbeck, S. L., Collins, J. M., & Doroshow, J. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0106 · Cited by 311
50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches
Suggitt, M., & Bibby, M. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.971.11.3 · Cited by 298
Komatsu, N., Nakauchi, H., Miwa, A., Ishihara, T., Eguchi, M., Moroi, M., Okada, M., Sato, Y., Wada, H., & Yawata, Y. (1991) · PubMed · Cited by 285
Dan, S., Tsunoda, T., Kitahara, O., Yanagawa, R., Zembutsu, H., Katagiri, T., Yamazaki, K., Nakamura, Y., & Yamori, T. (2002) · PubMed · Cited by 277
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Goodspeed, A., Heiser, L. M., Gray, J. W., & Costello, J. C. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0189 · Cited by 276
Henrietta lacks, HeLa cells, and cell culture contamination
Lucey, B. P., Nelson-Rees, W. A., & Hutchins, G. M. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.9.1463 · Cited by 255
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Li, J., Zhao, W., Akbani, R., Liu, W., Ju, Z., Ling, S., Vellano, C. P., Roebuck, P., Yu, Q., Eterovic, A. K., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.005 · Cited by 209
False leukemia–lymphoma cell lines: an update on over 500 cell lines
Drexler, H. G., Dirks, W. G., Matsuo, Y., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2402799 · Cited by 202 · cited 1×
“In a study that was conducted at Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ), 18% of 252 “new” continuous hematopoietic cell lines were cross-contaminated [62].”
van der Meer, D., Barthorpe, S., Yang, W., Lightfoot, H., Hall, C., Gilbert, J., Francies, H. E., & Garnett, M. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky872 · Cited by 195
Chen, W., Lu, G., Chen, X., Zhao, X., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1013 · Cited by 171
Sandberg, R., & Ernberg, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408105102 · Cited by 169
Contamination of Human Cell Cultures by Pleuropneumonialike Organisms
Robinson, L. B., Wichelhausen, R. H., & Roizman, B. (1956) · Science · doi:10.1126/science.124.3232.1147 · Cited by 156 · cited 1×
“This problem was first proposed in 1956, when it was discovered as a cell culture contaminant [68].”
BackgroundLessons from HeLa Cells: The Ethics and Policy of Biospecimens
Beskow, L. M. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022536 · Cited by 146 · cited 1×
“The advent of cancer cell lines, with the stabilization of the HeLa cell line, revolutionized the approach to in vitro cancer research [23,87].”
BackgroundCurrent management of newly diagnosed acute promyelocytic leukemia
Cicconi, L., & Lo‐Coco, F. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw171 · Cited by 145
Falini, B., Flenghi, L., Fagioli, M., Lo‐Coco, F., Cordone, I., Diverio, D., Pasqualucci, L., Biondi, A., Riganelli, D., Orleth, A., et al. (1997) · Blood · doi:10.1182/blood.v90.10.4046 · Cited by 137
The LL-100 panel: 100 cell lines for blood cancer studies
Quentmeier, H., Pommerenke, C., Dirks, W. G., Eberth, S., Koeppel, M., MacLeod, R. A. F., Nagel, S., Steube, K. G., Uphoff, C. C., & Drexler, H. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-44491-x · Cited by 126
Drexler, H. G., MacLeod, R. A., & Uphoff, C. C. (1999) · Leukemia Research · doi:10.1016/s0145-2126(98)00171-4 · Cited by 125
Establishment and characterization of human B cell precursor-leukemia cell lines
Matsuo, Y., & Drexler, H. G. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00050-2 · Cited by 117
Drexler, H. G., & Matsuo, Y. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00195-2 · Cited by 116
The Genus Mycoplasma and Related Genera (Class Mollicutes)
Razin, S. (2006) · Springer eBooks · doi:10.1007/0-387-30744-3_29 · Cited by 110
Continuous hematopoietic cell lines as model systems for leukemia–lymphoma research
Drexler, H. G., Matsuo, Y., & MacLeod, R. A. F. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00070-9 · Cited by 110
Weinstein, J. N. (2012) · Nature · doi:10.1038/483544a · Cited by 109
CULTIVATION IN VITRO OF MALIGNANT TUMORS
Carrel, A., & Burrows, M. T. (1911) · The Journal of Experimental Medicine · doi:10.1084/jem.13.5.571 · Cited by 101
Embryonic transplantation and development of the nervous system
Harrison, R. G. (1908) · The Anatomical Record · doi:10.1002/ar.1090020902 · Cited by 97
Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia
Drexler, H. G., Quentmeier, H., MacLeod, R. A. F., Uphoff, C. C., & Hu, Z. (1995) · Leukemia Research · doi:10.1016/0145-2126(95)00036-n · Cited by 96
Species-Specific PCR for Identification of Common Contaminant Mollicutes in Cell Culture
Kong, F., James, G. S., Gordon, S., Zelynski, A., & Gilbert, G. L. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.7.3195-3200.2001 · Cited by 95
Guidelines for the characterization and publication of human malignant hematopoietic cell lines
Drexler, H. G., & Matsuo, Y. (1999) · Leukemia · doi:10.1038/sj.leu.2401428 · Cited by 82
O'Dwyer, M. E., & Druker, B. J. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00149-2 · Cited by 75
Mix-ups and mycoplasma: the enemies within
Drexler, H. G., Uphoff, C. C., Dirks, W. G., & MacLeod, R. A. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00136-9 · Cited by 66
Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations
Drexler, H. G., Quentmeier, H., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2403236 · Cited by 61
Precision medicine driven by cancer systems biology
Filipp, F. V. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9662-4 · Cited by 59
Anticancer drug development at the US National Cancer Institute
Takimoto, C. H. M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0623-y · Cited by 58
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
Russo, V. M., Paciocco, A., Affinito, A., Roscigno, G., Fiore, D., Palma, F., Galasso, M., Volinia, S., Fiorelli, A., Esposito, C. L., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.016 · Cited by 58
Longo, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejme1700833 · Cited by 54
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in Human and Other Primate Cell Lines
Uphoff, C. C., Denkmann, S. A., Steube, K. G., & Drexler, H. G. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/904767 · Cited by 51
In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer.
Rockwell, S. (1980) · PubMed · Cited by 48
History of leukemia-lymphoma cell lines
Drexler, H. G., & MacLeod, R. A. F. (2010) · Human Cell · doi:10.1111/j.1749-0774.2010.00087.x · Cited by 44
Turner, T. (2012) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2012.0151 · Cited by 44
Incidences of problematic cell lines are lower in papers that use RRIDs to identify cell lines
Babic, Z., Capes-Davis, A., Martone, M. E., Bairoch, A., Ozyurt, I. B., Gillespie, T. H., & Bandrowski, A. E. (2019) · eLife · doi:10.7554/elife.41676 · Cited by 44 · cited 1×
“org/) created a website that is dedicated to the authentication of cell lines [67].”
BackgroundResponsibility for truth in research
Nelson‐Rees, W. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0873 · Cited by 41
Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia
Drexler, H. G., Matsuo, Y., & MacLeod, R. A. F. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.03.022 · Cited by 34
Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia
Drexler, H. G. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90103-1 · Cited by 32
Hodgkin lymphoma cell lines: to separate the wheat from the chaff
Drexler, H. G., Pommerenke, C., Eberth, S., & Nagel, S. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0321 · Cited by 32
3D-3 Tumor Models in Drug Discovery for Analysis of Immune Cell Infiltration
Oßwald, A., Hedrich, V., & Sommergruber, W. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9145-7_10 · Cited by 31
Database of misidentified cell lines
Freshney, R. I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24998 · Cited by 28
Close, D. A., Wang, A. X., Kochanek, S. J., Shun, T., Eiseman, J. L., & Johnston, P. A. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218812429 · Cited by 26
Mariotti, E., Gemei, M., Mirabelli, P., D’Alessio, F., Noto, R. D., Fortunato, G., & Vecchio, L. D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-120 · Cited by 25
Self-citationGonzalez‐Nicolini, V., & Fussenegger, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00001 · Cited by 23
Prevention of mycoplasma contamination in leukemia-lymphoma cell lines.
Cc, U., & Drexler, H. G. (2001) · PubMed · Cited by 17
A Biomarker Harvest from One Thousand Cancer Cell Lines
Huang, Y., & Vakoc, C. R. (2016) · Cell · doi:10.1016/j.cell.2016.07.010 · Cited by 17
Drexler, H. G., Ehrentraut, S., Nagel, S., Eberth, S., & MacLeod, R. A. F. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.002 · Cited by 13
Robustin-silicoidentification of cancer cell lines based on next generation sequencing
Otto, R., Sers, C., & Leser, U. (2017) · Oncotarget · doi:10.18632/oncotarget.16110 · Cited by 12
The Impact of Microenvironment on the Synovial Sarcoma Transcriptome
Jin, H., Barrott, J. J., Cable, M. G., Monument, M. J., Lerman, D. M., Smith-Fry, K., Nollner, D., & Jones, K. B. (2017) · Cancer Microenvironment · doi:10.1007/s12307-017-0192-y · Cited by 12
Divergent expression of CD133 in different studies on HCT‐116 cell line
Gemei, M., Mirabelli, P., Noto, R. D., Fortunato, G., & Vecchio, L. D. (2010) · International Journal of Cancer · doi:10.1002/ijc.25406 · Cited by 7
Self-citation
Cited by
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
Rizzo, G., Bertotti, A., Leto, S. M., & Vetrano, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01970-2 · Cited by 51
Glioblastoma modeling with 3D organoids: progress and challenges
Wang, X., Sun, Y., Zhang, D. Y., Ming, G.-L., & Song, H. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad008 · Cited by 46
“Patient-derived 2D cell lines have been commonly used as convenient and well-established experimental tools [25–27].”
MethodZhuang, Y., Grainger, J. M., Vedell, P. T., Yu, J., Moyer, A. M., Gao, H., Fan, X.-Y., Qin, S., Liu, D., Kalari, K. R., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00285-x · Cited by 11
Metadata
- Authors
- Mirabelli, P., Coppola, L., & Salvatore, M.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-08-01
- Volume
- 11
- Issue
- 8
- Pages
- 1098
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2965206386
- Cited by
- 336
- References
- 86
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.